The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical cardiology"
DOI: 10.1002/clc.23807
Abstract: BACKGROUND The duration of beta-blocker therapy in patients without heart failure (HF) or left ventricular systolic dysfunction after acute myocardial infarction (AMI) is unclear. HYPOTHESIS Continuous beta-blocker therapy is associated with an improved prognosis. METHODS… read more here.
Keywords: beta blocker; continuous beta; blocker therapy;
Clinical outcomes with digoxin vs. beta‐blocker for heart rate control in permanent atrial fibrillation with heart failure
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2292
Abstract: Since the DIG study,1 which demonstrated that whilst digoxin reduced hospitalization for heart failure (HF), there was no significant overall effect on mortality, the place of digoxin in treating HF has steadily declined over recent… read more here.
Keywords: digoxin; heart; beta blocker; heart failure ... See more keywords
Effect of beta‐blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2737
Abstract: In the EXPLORER‐HCM trial, mavacamten improved exercise capacity and symptoms in patients with obstructive hypertrophic cardiomyopathy (oHCM). Mavacamten effects on the primary endpoint, a composite of peak oxygen consumption (VO2) and New York Heart Association… read more here.
Keywords: beta blocker; hypertrophic cardiomyopathy; obstructive hypertrophic; beta ... See more keywords
Effects of sacubitril/valsartan according to background beta‐blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM‐HF
Sign Up to like & getrecommendations! Published in 2024 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.3515
Abstract: Beta‐blockers may inhibit neprilysin activity and conversely, neprilysin inhibition may have a sympatho‐inhibitory action. Consequently, sacubitril/valsartan may have a greater effect in patients not receiving a beta‐blocker compared to those treated with a beta‐blocker. read more here.
Keywords: sacubitril valsartan; beta blocker; beta; heart failure ... See more keywords
Use of beta‐blockers and risk of contralateral breast cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.33923
Abstract: Beta‐blockers have shown antineoplastic effects in laboratory studies but epidemiologic evidence in relation to contralateral breast cancer (CBC) is sparse. We investigated postdiagnosis beta‐blocker use and risk of CBC in a cohort of 52 723 women… read more here.
Keywords: beta blocker; breast cancer; use; beta ... See more keywords
Target Trial Emulation of Beta-Blockers After Diagnosis of Colorectal Polyps-Beneficial in Women.
Sign Up to like & getrecommendations! Published in 2025 at "United European gastroenterology journal"
DOI: 10.1002/ueg2.70139
Abstract: ABSTRACT Background and Aims Beta‐blockers are successfully used to treat hemangioma and may decrease the proliferation of cancer cells. We hypothesized that individuals with colorectal polyps may also benefit from beta‐blocker initiation. Methods Individuals diagnosed… read more here.
Keywords: beta blocker; crc; mortality; beta ... See more keywords
β-Adrenergic blockade in patients with dementia and hip fracture is associated with decreased postoperative mortality
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Trauma and Emergency Surgery"
DOI: 10.1007/s00068-021-01723-y
Abstract: Dementia, present in 20% of hip fracture patients, is associated with an almost threefold increase in postoperative mortality risk. These patients have a substantially higher incidence of cardiovascular, respiratory, and cerebrovascular mortality after hip fracture… read more here.
Keywords: postoperative mortality; mortality; hip fracture; beta blocker ... See more keywords
Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias
Sign Up to like & getrecommendations! Published in 2022 at "Heart and Vessels"
DOI: 10.1007/s00380-021-02018-3
Abstract: The study investigates the prognostic significance of beta-blocker (BB) dose in patients with ventricular tachyarrhythmias. Limited data regarding the prognostic impact of BB dose in ventricular tachyarrhythmias is available. A large retrospective registry was used… read more here.
Keywords: patients ventricular; ventricular tachyarrhythmias; beta blocker; target dose ... See more keywords
Beta-blocker and ACE-inhibitor Dosing as a Function of Body Surface Area: From the HF-ACTION trial.
Sign Up to like & getrecommendations! Published in 2020 at "American heart journal"
DOI: 10.1016/j.ahj.2020.11.003
Abstract: Recognizing that body surface area (BSA) is a commonly used metric to inform medication dosing across fields of medicine, it is possible that patients with heart failure with reduced ejection fraction (HFrEF) with higher BSA… read more here.
Keywords: action trial; beta blocker; body surface; surface area ... See more keywords
Dose Response Relationship of RAS Blocker and beta-Blocker in Patients with Acute Heart Failure Syndrome: Data from the Korean Acute Hart Failure (KorAHF) Registry
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cardiac Failure"
DOI: 10.1016/j.cardfail.2019.07.411
Abstract: Background Whether patients with acute heart failure syndrome (AHFS) need to reach the target dose of renin-angiotensin-system (RAS) blocker and beta-blocker to obtain a benefit in terms of clinical outcome remain uncertain. We aimed to… read more here.
Keywords: blocker; blocker beta; failure; ras blocker ... See more keywords
TCTAP A-149 Impact of Beta-blocker on Long-term Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusion: Data from Decision-CTO Registry
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.03.109
Abstract: The clinical impact of beta-blocker therapy after percutaneous coronary intervention for chronic total occlusion (CTO) is not well established. So we evaluated the clinical influence of beta-blocker therapy on percutaneous coronary chronictotal occlusion intervention. This… read more here.
Keywords: percutaneous coronary; intervention; occlusion; beta blocker ... See more keywords